TN2010000015A1 - Stable formulations of thiadiazole derivative - Google Patents

Stable formulations of thiadiazole derivative

Info

Publication number
TN2010000015A1
TN2010000015A1 TNP2010000015A TN2010000015A TN2010000015A1 TN 2010000015 A1 TN2010000015 A1 TN 2010000015A1 TN P2010000015 A TNP2010000015 A TN P2010000015A TN 2010000015 A TN2010000015 A TN 2010000015A TN 2010000015 A1 TN2010000015 A1 TN 2010000015A1
Authority
TN
Tunisia
Prior art keywords
stable formulations
thiadiazole derivative
ethanesulfonylamino
dimeth
thiadiazol
Prior art date
Application number
TNP2010000015A
Other languages
English (en)
Inventor
Hiroko Kusano
Dinesh Shyamdeo Mishra
Yoshikazu Tashiro
Yosuke Watanabe
Hong Huang
Original Assignee
Kyowa Hakko Kogyo Kk
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39735000&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2010000015(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kogyo Kk, Lilly Co Eli filed Critical Kyowa Hakko Kogyo Kk
Publication of TN2010000015A1 publication Critical patent/TN2010000015A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TNP2010000015A 2007-07-12 2010-01-08 Stable formulations of thiadiazole derivative TN2010000015A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94926807P 2007-07-12 2007-07-12
PCT/US2008/069301 WO2009009470A1 (fr) 2007-07-12 2008-07-07 Formulations stables de dérivé du thiadiazole

Publications (1)

Publication Number Publication Date
TN2010000015A1 true TN2010000015A1 (en) 2011-09-26

Family

ID=39735000

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000015A TN2010000015A1 (en) 2007-07-12 2010-01-08 Stable formulations of thiadiazole derivative

Country Status (28)

Country Link
US (1) US8222284B2 (fr)
EP (1) EP2178508B1 (fr)
JP (1) JP4875205B2 (fr)
KR (1) KR101188036B1 (fr)
CN (1) CN101730525A (fr)
AR (1) AR067472A1 (fr)
AU (1) AU2008275258A1 (fr)
BR (1) BRPI0814039A2 (fr)
CA (1) CA2694277C (fr)
CL (1) CL2008001996A1 (fr)
CO (1) CO6270304A2 (fr)
CR (1) CR11210A (fr)
DO (1) DOP2010000004A (fr)
EA (1) EA016861B1 (fr)
EC (1) ECSP109864A (fr)
ES (1) ES2401477T3 (fr)
GT (1) GT201000003A (fr)
HK (1) HK1141238A1 (fr)
IL (1) IL202382A0 (fr)
MA (1) MA31880B1 (fr)
MX (1) MX2010000468A (fr)
NZ (1) NZ581791A (fr)
PE (1) PE20090438A1 (fr)
SV (1) SV2010003449A (fr)
TN (1) TN2010000015A1 (fr)
TW (1) TW200918050A (fr)
UA (1) UA97672C2 (fr)
WO (1) WO2009009470A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2447536B1 (fr) 2009-06-26 2017-12-27 Mitsubishi Electric Corporation Compresseur à réfrigérant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003051854A1 (fr) 2001-12-11 2003-06-26 Kyowa Hakko Kogyo Co., Ltd. Dérivé de thiadiazolines
ATE537158T1 (de) * 2003-04-18 2011-12-15 Kyowa Hakko Kirin Co Ltd M-stage-kinesin-inhibitor
JP2006265107A (ja) * 2005-03-22 2006-10-05 Kyowa Hakko Kogyo Co Ltd 緑内障治療剤
KR20070114822A (ko) * 2005-03-22 2007-12-04 교와 핫꼬 고교 가부시끼가이샤 조혈기 종양 치료제
JP2008150291A (ja) * 2005-03-22 2008-07-03 Kyowa Hakko Kogyo Co Ltd 乾癬治療剤
JP2008137893A (ja) * 2005-03-22 2008-06-19 Kyowa Hakko Kogyo Co Ltd 関節炎治療剤
AU2006225636A1 (en) 2005-03-22 2006-09-28 Fujifilm Corporation Therapeutic agent for solid tumor
US7910611B2 (en) * 2005-06-24 2011-03-22 Kyowa Hakko Kirin Co., Ltd. Therapeutic agent for restenosis

Also Published As

Publication number Publication date
CA2694277A1 (fr) 2009-01-15
CA2694277C (fr) 2013-04-09
US20110009458A1 (en) 2011-01-13
CR11210A (es) 2010-06-23
JP2010533190A (ja) 2010-10-21
EA201070136A1 (ru) 2010-06-30
KR101188036B1 (ko) 2012-10-05
JP4875205B2 (ja) 2012-02-15
CL2008001996A1 (es) 2009-05-22
IL202382A0 (en) 2010-06-30
WO2009009470A1 (fr) 2009-01-15
DOP2010000004A (es) 2010-03-15
GT201000003A (es) 2012-03-13
EP2178508A1 (fr) 2010-04-28
HK1141238A1 (en) 2010-11-05
ES2401477T3 (es) 2013-04-19
MX2010000468A (es) 2010-04-09
TW200918050A (en) 2009-05-01
AR067472A1 (es) 2009-10-14
CO6270304A2 (es) 2011-04-20
NZ581791A (en) 2012-03-30
SV2010003449A (es) 2010-08-10
AU2008275258A1 (en) 2009-01-15
EP2178508B1 (fr) 2013-02-06
UA97672C2 (ru) 2012-03-12
KR20100029827A (ko) 2010-03-17
ECSP109864A (es) 2010-03-31
BRPI0814039A2 (pt) 2017-10-03
EA016861B1 (ru) 2012-08-30
MA31880B1 (fr) 2010-12-01
US8222284B2 (en) 2012-07-17
CN101730525A (zh) 2010-06-09
PE20090438A1 (es) 2009-04-18

Similar Documents

Publication Publication Date Title
WO2009082152A3 (fr) Activateurs de la glucokinase et compositions pharmaceutiques contenant ces derniers en tant qu'ingrédient actif
EP1725536B8 (fr) Derives de l'imidazoline presentant une activite antagoniste cb1
WO2010001169A3 (fr) Composés chimiques 251
AU2011338389A8 (en) Bicyclic compounds as Pim inhibitors
WO2008030412A3 (fr) Inhibiteurs de la spiropipéridine bêta-sécrétase pour le traitement de la maladie d'alzheimer
WO2007011833A3 (fr) Inhibiteurs de spiropiperidine beta-secretase pour le traitement de la maladie d'alzheimer
WO2010103130A3 (fr) Nouveaux hétérocycles bicycliques
WO2008054698A3 (fr) Composés de spiropipéridine inhibiteurs de la bêta-sécrétase pour le traitement de la maladie d'alzheimer
CA2757418C (fr) Formulations pharmaceutiques contenant des derives de nitrocatechol et procedes pour les preparer
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
WO2007058862A3 (fr) Composes d’imidazolidinone utiles en tant qu’inhibiteurs de la beta-secretase lors du traitement de la maladie d’alzheimer
EP2599475A3 (fr) Composition pharmaceutique à biodisponibilité souhaitable
WO2009105969A8 (fr) Analogues d'épothilone, leurs compositions pharmaceutiques, leur utilisation et leurs préparations
EP2142549A4 (fr) Dérivés d'adénosine, procédé pour la synthèse de ces derniers, et compositions pharmaceutiques pour la prévention et le traitement de maladies inflammatoires contenant lesdits dérivés en tant qu'ingrédients actifs
WO2009060952A1 (fr) Nouvelle préparation
UA84896C2 (ru) Производные гидронопола как агонисты человеческих рецепторов orl1
WO2006021401A3 (fr) Derives de bicyclononene
WO2007081808A3 (fr) Composes et derives pour le traitement d’etats medicaux par modulation de l’activite de la lipase hormono-sensible
EP2371379A3 (fr) Nouvelle formulation pour augmenter la biodisponibilité de la neurturine
WO2008033930A3 (fr) Dérivés de vinca
TN2010000015A1 (en) Stable formulations of thiadiazole derivative
WO2009096667A3 (fr) Nouveau dérivé de quinazoline-2,4-dione et compositions médicales pour la prophylaxie et le traitement de la maladie du nerf crânien contenant ledit dérivé
WO2008135830A8 (fr) Dérivés de pyrazine
WO2006131884A3 (fr) Nouveaux derives de thiazole
WO2007047881A3 (fr) Methode de traitement de la douleur